Metsera is leaving no fundraising stone unturned as it races to grab a slice of the fast-growing market for obesity drugs. Just nine months after emerging from stealth with a $290 million Series A and ...

Editor's note: This story was updated to correct a typo in a quote. By 25, Zackery Leffler had been a soccer standout, peer tutor and company founder with a fiancé and a wide circle of friends. When ...